MINDACT: (EORTC) A Prospective, Randomised Study Comparing the 70-Gene Signature with the Common Clinical-Pathological Criteria in Selecting Patients for Adjuvant Chemotherapy in Node-Negative Breast Cancer (year 4 renewal)

  • Thompson, Alastair, (Investigator)
StatusFinished
Effective start/end date1/10/1230/09/17

Funding

  • Cancer Research UK (C7636/A7714): £10,346.00
  • Cancer Research UK: £10,759.71
  • Cancer Research UK: £11,637.97
  • Cancer Research UK: £9,947.91
  • Cancer Research UK: £11,190.09